C9orf72 and amyotrophic lateral sclerosis: Schönecker’s study subsequently showed thalamic atrophy in ALS/FTD C9orf72 mutation carriers that extended beyond the expected atrophy in the prefrontal and temporal subregions (Schönecker et al., 2018).